Although RNF213 patients were on average younger at onset than NF1 patients (35.2 ± 35.5 versus 64.4 ± 41.3 months), this difference did not reach statistical significance as a result of incidentally diagnosed patients being excluded from the analysis (p = 0.0521). The gene discussed is RNF213; the disease is neurofibromatosis type 1.